| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Dambkowski Carl serves as a Chief Medical Officer at APGE. Across recent SEC filings that breaks down to 0 buys and 43 sells. Those positions are worth an estimated $23.5M at current prices.
Historically, Dambkowski Carl's trades have earned a below-average insider score of 47/100 across 20 rated trades. Over a 12-month horizon, 28.6% of those trades were profitable, with an average 12-month return of -47.9%.
The biggest single holding is APGE (~$23.5M) as Chief Medical Officer. The recent filings there lean toward selling, a net 161,470 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 4, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 2,725 | $36.96 | $100,716.00 | -1.1% | +3.7% | +149.0% | |
| May 7, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 2,725 | $35.75 | $97,418.75 | -1.1% | +8.8% | +132.2% | |
| Apr 2, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 3,860 | $36.22 | $139,801.27 | -0.5% | +17.0% | +122.9% | |
| Mar 5, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 1,590 | $30.48 | $48,463.20 | -0.6% | +18.0% | +125.8% | |
| Feb 5, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 3,520 | $40.69 | $143,228.80 | -1.4% | -13.9% | +50.3% | |
| Jan 2, 2025 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 4,085 | $46.94 | $191,739.64 | -0.5% | -19.8% | +60.7% | |
| Dec 11, 2024 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 4,540 | $48.76 | $221,362.70 | -0.9% | -17.4% | +56.9% | |
| Dec 4, 2024 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 6,665 | $46.07 | $307,056.55 | -2.5% | -41.6% | +45.1% | |
| Nov 6, 2024 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 6,665 | $59.12 | $394,041.10 | -1.2% | -31.2% | -6.5% | |
| Oct 2, 2024 | APGE Apogee Therapeutics, Inc. | Chief Medical Officer | Sell | 6,665 | $56.26 | $374,953.90 | -1.2% | -19.4% | -29.6% |